These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17178358)

  • 1. Attention-deficit hyperactivity disorder.
    Wolraich ML
    Semin Pediatr Neurol; 2006 Dec; 13(4):279-85. PubMed ID: 17178358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment.
    Manassis K
    Expert Rev Neurother; 2007 Aug; 7(8):981-8. PubMed ID: 17678493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of perceptions, attitudes, and level of knowledge among pediatricians towards attention-deficit/hyperactivity disorder.
    Hirfanoğlu T; Soysal AS; Gücüyener K; Cansu A; Serdaroğlu A
    Turk J Pediatr; 2008; 50(2):160-6. PubMed ID: 18664081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD).
    Toplak ME; Bucciarelli SM; Jain U; Tannock R
    Child Neuropsychol; 2009 Jan; 15(1):53-72. PubMed ID: 18608232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The predictive value of DSM-IV criteria in the diagnosis of attention deficit hyperactivity disorder and its cultural differences].
    Cardo E; Bustillo M; Servera M
    Rev Neurol; 2007 Mar; 44 Suppl 2():S19-22. PubMed ID: 17347938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?
    Antshel KM; Faraone SV; Maglione K; Doyle A; Fried R; Seidman L; Biederman J
    Psychol Med; 2009 Aug; 39(8):1325-35. PubMed ID: 19105857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADHD in children, adolescents, and adults.
    Katragadda S; Schubiner H
    Prim Care; 2007 Jun; 34(2):317-41; abstract viii. PubMed ID: 17666230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nature of anxiety comorbid with attention deficit hyperactivity disorder in children from a pediatric primary care setting.
    Bowen R; Chavira DA; Bailey K; Stein MT; Stein MB
    Psychiatry Res; 2008 Jan; 157(1-3):201-9. PubMed ID: 18023880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical variability and characteristics of attention deficit hyperactivity disorder in girls].
    Valdizán JR; Mercado E; Mercado-Undanivia A
    Rev Neurol; 2007 Mar; 44 Suppl 2():S27-30. PubMed ID: 17347940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Motor assessment in school-aged children with indicators of the attention deficit/hyperactivity disorder].
    Poeta LS; Rosa-Neto F
    Rev Neurol; 2007 Feb 1-15; 44(3):146-9. PubMed ID: 17285518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches.
    Mohammadi MR; Akhondzadeh S
    Expert Rev Neurother; 2007 Feb; 7(2):195-201. PubMed ID: 17286552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of attention in children with attention deficit hyperactivity disorder (an analytical review)].
    Krupskaia EV; Machinskaia RI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(6):731-41. PubMed ID: 17285768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric study of the test of variables of attention: preliminary findings on Taiwanese children with attention-deficit/hyperactivity disorder.
    Wu YY; Huang YS; Chen YY; Chen CK; Chang TC; Chao CC
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):211-8. PubMed ID: 17472587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.